Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Aquilo Capital Management

Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • USA
  • California
  • Massachusetts
  • Connecticut
  • New Jersey
  • Belgium
  • East Flanders
  • Denmark
  • Copenhagen
Investment stages
  • Seed
  • Series A
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Data Science
About
Aquilo Capital Management is a biotech hedge fund that invests in drug development companies leveraging scientific breakthroughs to revolutionize medicine, using a disciplined, value‑oriented process and deep sector expertise.
Min check size
$1M
Max check size
$3M
Fund size
NPS

Investment Thesis

Aquilo Capital invests in drug development companies that harness the poTheyr of cuttingedge science to address urgent medical needs.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Focused on technology and consumer sectors, the fund manager has successfully led over 50 deals across North America and Europe. Known for a growth-oriented investment style, they emphasize early-stage opportunities with a track record of substantial exits. Backed by a top-tier network, their strategy combines rigorous analysis with an operator-first approach, resulting in high returns and impactful scaling. Specializes in identifying disruptive trends, positioning their portfolio for long-term success in competitive markets.

Aquilo Capital Management Contacts Information

Primary contact

Team

Patrick Rivers

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp